Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma

Background: Glioma is the primary malignant tumor of the central nervous system and presents high mortality and disability rates under existing treatment measures. Thioredoxin domain-containing 12 (TXNDC12) has been shown to play an important role in various malignant tumors. Therefore, we explored...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinzhuang, Yang, Quan, Liu, Nan, Bian, Qilong, Gao, Ming, Hou, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493877/
https://www.ncbi.nlm.nih.gov/pubmed/34629960
http://dx.doi.org/10.3389/pore.2021.1609825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493877/
https://www.ncbi.nlm.nih.gov/pubmed/34629960
http://dx.doi.org/10.3389/pore.2021.1609825

Ejemplares similares